美國的傳染病檢查市場預測:成長機會及產業擴大策略

本報告提供美國的傳染病檢查市場相關調查分析，提供全球市場及技術概要，美國市場現況與今後十年間的未來預測，主要的產品開發機會，打入市場策略等驗證，也包含主要企業簡介，為您概述為以下內容。

簡介

全球市場及技術概要

• 主要的傳染病檢查
  • 愛滋病
  • 腺病毒
  • 產氣單胞菌
  • 炭疽病
  • 蟲媒病毒
  • 犬焦蟲症
  • 桿菌性血骨病•巴通氏菌傳染病
  • 人芽囊原蟲感染症
  • 布氏桿菌症
  • 曲狀桿菌症
  • 念珠菌感染
  • 南美錐蟲病
  • 軟性下疳
  • 披衣菌感染
  • 艱難梭狀芽胞桿菌感染症
  • 犬冠狀病毒
  • 克沙奇病毒等等
• 設備評估和市場需求
• 新興診斷技術
  • (DNA)核酸探針
  • 單株抗體
  • 免疫測量
  • 光散射分析
  • 微電腦與自動化
  • 人工智能
  • 微脂體
  • 流式細胞技術
  • 層析法
  • MRI
  • 凝膠微滴法
  • 其他

美國市場

• 摘要整理
• 商務環境
• 市場結構
• 市場規模與成長，主要業者

主要的產品開發機會

• 設備
• 試劑組和檢查系統/操作面板
• 電腦，軟體，自動化
• 輔助產品

分散式檢查產品的設計標準

打入市場策略

• 國內開發
• 共同開發
• 與大學的契約
• 流通策略

潛在的打入市場的障礙與風險

• 市場成熟度
• 成本控制
• 競爭
• 在技術方面的優勢與限制
• 專利保護
• 法規限制
• 分散式檢查市場課題

競爭企業各公司的評估

圖表

This report presents a comprehensive analysis of the US infectious disease testing market, including:

• Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
• Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
• Ten-year test volume and sales forecasts for nearly 80 infectious disease testing performed in US hospitals, blood banks, physician offices, public health and commercial laboratories.
• Instrumentation technologies and feature comparison of leading analyzers.
• Sales and market shares of leading suppliers.
• Emerging diagnostic technologies and their potential market applications.
• Product development opportunities.
• Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Business opportunities and strategic recommendations for suppliers.

Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the healthcare, biotechnology, chemical, food and beverage, electronics, and other industries.

VPG has served over 1,000 corporations in 70 countries, and has established a broad network of domestic and international contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government.

Introduction

Worldwide Market and Technology Overview

• A. Major Infectious Disease Tests
  • 1. AIDS
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 2. Adenovirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
    • d. Adeno-Associated Viruses(AAV)
  • 3. Aeromonas
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 4. Anthrax/Bacillus Anthracis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 5. Arboviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 6. Babesiosis
    • a. Background
  • 7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 8. Blastocystis Hominis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 9. Brucella
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 10. Campylobacter
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 11. Candida
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 12. Chagas Disease
    • a. Background
  • 13. Chancroid
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 14. Chlamydia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 15. Clostridium Difficile
    • a. Background
    • b. Diagnostic Tests
    • c. Drugs and Vaccines
  • 16. Coronaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 17. Coxsackieviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 18. Creutzfeldt-Jakob's Disease
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines
  • 19. Cryptosporidium Parvum
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 20. Cyclospora Cayetanensis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 21. Cytomegalovirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 22. Ebola Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 23. E. Coli
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 24. EchoVirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 25. Encephalitis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 26. Enteroviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 27. Epstein-Barr Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 28. Giardia Lamblia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 29. Gonorrhea
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 30. Granuloma Inguinale
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 31. Hantavirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 32. Helicobacter Pylori
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 33. Hepatitis
    • a. Background
    • b. Hepatitis A
    • c. Hepatitis B
    • d. Hepatitis C
    • e. Vaccines and Drugs
  • 34. Herpes Simplex Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 35. Human Herpes Virus-6 (HHV-6)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 36. Influenza Viruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 37. Legionella
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 38. Lyme Disease
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 39. Lymphogranuloma Venereum (LGV)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 40. Malaria
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 41. Measles (Rubeola)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 42. Meningitis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 43. Microsporidium
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 44. Mononucleosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 45. Mumps
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 46. Mycoplasma
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 47. Papillomaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 48. Parvovirus B19
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 49. Pneumonia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 50. Polyomaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 51. Pseudomonas Aeruginosa
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 52. Rabies
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 53. Respiratory Syncytial Virus (RSV)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 54. RhinoViruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 55. RotaVirus (REOVIRUS)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 56. Rubella(MEASLES)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 57. Salmonellosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 58. Septicemia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 59. Shigellosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 60. Staphylococcus Aureus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 61. Streptococci
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 62. Syphilis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 63. Toxoplasmosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 64. Trichomonas Vaginalis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 65. Tuberculosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 66. Vibrio
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 67. West Nile Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 68. Yersina
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
• B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
• C. Emerging Diagnostic Technologies
  • 1. Molecular Diagnostics
  • 2. Monoclonal Antibodies
  • 3. Immunoassays
  • 4. Differential Light Scattering
  • 5. Information Technology
  • 6. Artificial Intelligence
  • 7. Liposomes
  • 8. Flow Cytometry
  • 9. Chromatography
  • 10. Diagnostic Imaging
  • 11. Gel Microdroplets
  • 12. Other

U.S.A.

• A. Executive Summary
• B. Business Environment
  • 1. Health Care Expenditures
  • 2. Cost Consciousness
  • 3. Reimbursement
  • 4. Industry Consolidation
  • 5. Managed Care
  • a. HMO
  • b. PPO
  • 6. Hospitals
  • 7. Admissions
  • 8. Length of Stay
  • 9. Industry Diversification
  • 10. Physician Demographics
  • 11. Population Aging
    • a. Chronic Illness
    • b. Disease Incidence
    • c. Susceptibility to Iatrogenesis
    • d. Multiple Illness Cases
  • 12. Laboratory Regulations
  • 13. FDA Reform
• C. Market Structure
  • 1. Centralized Testing
    • a. Hospitals
    • b. Commercial/Private Laboratories
    • c. Blood Banks
      • 1) Community and Regional Centers
      • 2) Plasma Fractionation Centers
  • 2. Decentralized Testing
    • a. Physician Offices/Group Practices
    • b. Point of Care Testing
    • c. Other Decentralized Testing Locations
• D. Market Size, Growth and Major Suppliers

Major Product Development Opportunities

• A. Instrumentation
• B. Reagent Kits and Test Systems/Panels
• C. Computers, Software and Automation
• D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

• A. Internal Development
• B. Collaborative Arrangements
• C. University Contracts
• D. Distribution Strategies for Decentralized Testing Markets
  • 1. Marketing Approaches
  • 2. Product Complexity
  • 3. Customer Preference
  • 4. Established Suppliers
  • 5. Emerging Suppliers
  • 6. Major Types of Distributors
  • 7. Market Segmentation

Potential Market Entry Barriers and Risks

• A. Market Maturity
• B. Cost Containment
• C. Competition
• D. Technological Edge and Limitations
• E. Patent Protection
• F. Regulatory Constraints
• G. Decentralized Testing Market Challenges

Competitive Assessments

• Abbott
• Affymetrix
• Beckman Coulter/Danaher
• Becton Dickinson
• bioMerieux
• Bio-Rad
• Cepheid
• Diamedix
• DiaSorin
• Eiken Chemical
• Enzo Biochem
• Fujirebio
• Gen-Probe
• Hologic
• ID Biomedical
• Innogenetics/Solvay
• Kreatech
• Life Technology
• Lonza
• Nanogen/Elitech
• Novartis Diagnostics
• Ortho-Clinical Diagnostics
• Qiagen
• Roche
• Scienion
• Sequenom
• SeraCare
• Siemens
• Takara Bio
• Thermo Fisher
• Wallac
• Wako

• Major Companies Developing or Marketing AIDS Tests
• Major Companies Developing or Marketing Adenovirus Tests
• Major Companies Developing or Marketing Bartonella Tests
• Major Companies Developing or Marketing Campylobacter Tests
• Major Companies Developing or Marketing Candida Tests
• Major Companies Developing or Marketing Chlamydia Tests
• Major Companies Developing or Marketing Clostridium Tests
• Major Companies Developing or Marketing Coronavirus Tests
• Major Companies Developing or Marketing Cryptosporidium Tests
• Major Companies Developing or Marketing CMV Tests
• Major Companies Developing or Marketing Echovirus Tests
• Major Companies Developing or Marketing Enterovirus Tests
• Major Companies Developing or Marketing EBV Tests
• Major Companies Developing or Marketing Giardia Tests
• Major Companies Developing or Marketing Gonorrhea Tests
• Major Companies Developing or Marketing Hantavirus Tests
• Major Companies Developing or Marketing Helicobacter Pylori Tests
• Major Companies Developing or Marketing Hepatitis Tests
• Major Companies Developing or Marketing Herpes Tests
• Major Companies Developing or Marketing Influenza Tests
• Major Companies Developing or Marketing Legionella Tests
• Major Companies Developing or Marketing Lyme Disease Tests
• Major Companies Developing or Marketing Lymphogranuloma Tests
• Major Companies Developing or Marketing Malaria Tests
• Major Companies Developing or Marketing Measles Tests
• Major Companies Developing or Marketing Meningitis Tests
• Major Companies Developing or Marketing Microsporidium Tests
• Major Companies Developing or Marketing Mononucleosis Tests
• Major Companies Developing or Marketing Mumps Tests
• Major Companies Developing or Marketing Mycoplasma Tests
• Major Companies Developing or Marketing Papilloma Virus Tests
• Major Companies Developing or Marketing Parvovirus Tests
• Major Companies Developing or Marketing Pneumonia Tests
• Major Companies Developing or Marketing RSV Tests
• Major Companies Developing or Marketing Rotavirus Tests
• Major Companies Developing or Marketing Rubella Tests
• Major Companies Developing or Marketing Salmonella Tests
• Major Companies Developing or Marketing Septicemia Tests
• Major Companies Developing or Marketing Shigella Tests
• Major Companies Developing or Marketing Staphylococci Tests
• Major Companies Developing or Marketing Streptococci Tests
• Major Companies Developing or Marketing Syphilis Tests
• Major Companies Developing or Marketing Toxoplasmosis Tests
• Major Companies Developing or Marketing Trichomonas Tests
• Major Companies Developing or Marketing Tuberculosis Tests
• Major Companies Developing or Marketing West Nile Tests
• Major Companies Developing or Marketing Yersinia Tests

• U.S.A. Summary Table
• All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Laboratories Performing Infectious Disease Tests by Market Segment
• U.S.A. Hospital Laboratories Performing Infectious Disease Tests by Bed Size
• U.S.A. Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
• U.S.A. Physician Office Laboratories Performing Infectious Disease Tests by Practice Size
• U.S.A. All Market Segments Infectious Disease Test Volume Forecast
• U.S.A. Hospital Laboratories Infectious Disease Test Volume Forecast
• U.S.A. Blood Banks Infectious Disease Test Volume Forecast
• U.S.A. Physician Office Laboratories Infectious Disease Test Volume Forecast
• U.S.A. Commercial/Private Laboratories Infectious Disease Test Volume Forecast
• U.S.A. Public Health Laboratories Infectious Disease Test Volume Forecast
• U.S.A. All Market Segments Infectious Disease Diagnostics Market Forecast
• U.S.A. Hospital Laboratories Infectious Disease Diagnostics Market Forecast
• U.S.A. Blood Banks Infectious Disease Diagnostics Market Forecast
• U.S.A. Physician Office Laboratories Infectious Disease Diagnostics Market Forecast
• U.S.A. Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
• U.S.A. Public Health Laboratories Infectious Disease Diagnostics Market Forecast
• U.S.A. HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. BEA Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Candida Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. CoxsackieVirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. CMV Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. EBV Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Anti-HBC Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Anti-HBS Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Measles Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Polyomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. RSV Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. West Nile Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
• U.S.A. AIDS Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Adenovirus Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Campylobacter Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Candida Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Chancroid Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Chlamydia Testing Market Diagnostics Sales by Major Supplier
• U.S.A. CMV Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Cryptosporidium Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Echovirus Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Enterovirus Testing Market Diagnostics Sales by Major Supplier
• U.S.A. EBV Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Giardia Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Hepatitis C Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Influenza Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Legionella Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Lyme Disease Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Measles Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Meningitis Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Mononucleosis Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Mumps Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Pneumonia Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Rabies Testing Market Diagnostics Sales by Major Supplier
• U.S.A. RSV Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Rotavirus Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Rubella Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Salmonella Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Septicemia Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Streptococci Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier
• U.S.A. Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier